Sign up to save your podcasts
Or
Share Making Sense of Weight-Loss Drugs’ Cost and Coverage
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Making Sense of Weight-Loss Drugs’ Cost and Coverage
GLP-1s like Ozempic and Wegovy are no longer in short supply, yet they still can cost more than $1,000 a month out of pocket. Wall Street Journal contributor Cheryl Winokur Munk joins host Callum Borchers to dig into why some people pay much more for weight-loss drugs than others.
Sign up for the WSJ's free Markets A.M. newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By The Wall Street Journal
4
16671,667 ratings
GLP-1s like Ozempic and Wegovy are no longer in short supply, yet they still can cost more than $1,000 a month out of pocket. Wall Street Journal contributor Cheryl Winokur Munk joins host Callum Borchers to dig into why some people pay much more for weight-loss drugs than others.
Sign up for the WSJ's free Markets A.M. newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like WSJ Your Money Briefing
View all
WSJ Opinion: Potomac Watch
2,842 Listeners
Motley Fool Money
3,238 Listeners
Investing Insights
526 Listeners
WSJ What’s News
4,413 Listeners
Bloomberg Intelligence
409 Listeners
Bloomberg Businessweek
436 Listeners
WSJ Tech News Briefing
1,649 Listeners
WSJ Minute Briefing
683 Listeners
Bold Names
1,448 Listeners
Wall Street Breakfast
1,048 Listeners
Thoughts on the Market
1,309 Listeners
The Journal.
6,104 Listeners
Barron's Streetwise
1,580 Listeners
Barron's Live
213 Listeners
Bad Bets
1,322 Listeners
WSJ Opinion: Free Expression
585 Listeners
As We Work
152 Listeners
The Markets
81 Listeners
WSJ's Take On the Week
149 Listeners